1/47
A set of vocabulary-style flashcards covering lifespan pharmacology concepts from the provided notes, including pregnancy, pediatric, and older adult considerations, dosing, Beers Criteria, and nursing process implications.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Pharmacokinetics Across the Lifespan
How absorption, distribution, metabolism, and excretion of drugs change as the body ages from infancy to old age.
Highest-Risk Age Groups for Drug Toxicity
Pediatric and older adult patients have the greatest risk for adverse effects and toxicity.
Most Drug Studies Population
Most studies are conducted in adults 13–65; pediatric use is often off-label with doses drawn from reference books.
Drug therapy during pregnancy
Fetus exposed to drugs mother takes.
Placental Transfer
Transfer of drugs from mother to fetus, occurring mainly by diffusion.
Drug Properties risks during pregnancy
chemistry (MW, lipid solubility, protein binding, structure), dose, duration, concurrent meds.
Gestational Age - First Trimester Risk
Greatest risk for birth defects due to rapid organogenesis.
Gestational Age - Third Trimester Risk
Highest percentage of maternal drug reaching the fetus because of increased blood flow and surface area and more free drug.
Maternal Factors Increasing Fetal Drug Exposure
Altered kidney/liver function and pharmacogenomics can raise fetal exposure to drugs.
FDA Pregnancy Classifications (A–X)
Traditional categories describing fetal risk: A, B, C, D, X.
FDA Category A
No risk to humans.
FDA Category B
No risk in animals; no human data.
FDA Category C
Adverse effects in animals; no human data.
FDA Category D
Possible risk in humans; benefits may outweigh risks.
FDA Category X
Fetal abnormalities—never use.
New Labeling System (2015+) Components
Label sections include Pregnancy, Lactation, and Females & Males of Reproductive Potential.
Impact of New Labeling System on Practice
Old A–X categories are still in use during transition; new sections guide prescribing decisions.
Drug Therapy During Breastfeeding
Many drugs pass into breast milk; risk is higher with fat-soluble, low molecular weight, high-concentration drugs; milk levels are usually lower than maternal blood levels.
Pediatric Definitions - Preterm
Preterm/premature: <38 weeks gestation.
Pediatric Definitions - Neonate
Birth to 1 month.
Pediatric Definitions - Infant
1 month to 1 year.
Pediatric Definitions - Child
1 year to 12 years.
Pediatric Absorption Factors
Less acidic gastric pH until 1–2 years; slowed gastric emptying; reduced first-pass metabolism; IM absorption faster and irregular.
Pediatric Distribution Factors
↑ total body water and ↑ fat stores; ↓ protein binding; immature BBB increases drug entry to the brain.
Pediatric Metabolism Factors
Immature liver with reduced microsomal enzymes.
Older kids may metabolize faster, need increased dose
Pediatric Excretion Factors
↓ GFR and tubular secretion; decreased renal perfusion leading to slower excretion.
Other Pediatric Risks
Thin skin (increased absorption potential), weak lung barriers, and poor temperature regulation leading to dehydration.
Dosage Calculations
Always use kg, not ins (1kg=2.2lb)
mg/kg/day or mg/kg/dose (watch carefully)
Safe range = min-max daily dose x kg
if dose outside safe range, do not give, clarify order .
Most common error: Pounds vs. Kilograms
Administration Considerations- Infants
Comfort (swaddling, Pacifier)
Administration Considerations - Toddlers
brief explanations, allow aggression within limits, comfort after.
Administration Considerations- Preschooler
short explanation, comfort, use magical thinking.
Administration Considerations- School Age
explain fully, therapeutic play, allow control.
Administration Considerations- Adolescents
Prepare in advance, respect privacy, encourage participation
Older Adult Defined
Individuals aged 65 years or older.
largest med-using population
increase chronic disease, Polypharmacy, noncompliance
Older Adult Pharmacokinetics - Absorption
↑ gastric pH, ↓ motility, ↓ blood flow, and ↓ surface area affect drug absorption.
Older Adult Pharmacokinetics - Distribution
↓ total body water → ↑ serum concentration of water-soluble drugs.
↑ fat → prolonged effects of fat-soluble drugs.
↓ albumin → ↑ free drug
Older Adult Pharmacokinetics - Metabolism
↓ liver enzyme activity and hepatic blood flow; prolonged half-life increases toxicity risk.
Older Adult Pharmacokinetics - Excretion
↓ renal blood flow, GFR, and nephron number; drugs cleared less effectively.
Problematic Medications in Older Adults
Analgesics (opioids, NSAIDs), Anticoagulants, Anticholinergics, Antihypertensives, Sedatives/Hypnotics/CNS depressants, Tricyclic antidepressants, Muscle relaxants.
Polypharmacy
Increase drug interactions
Beers Criteria (2019)
A list of drugs unsafe or to be used with caution in older adults.
Prescribing Cascade
One drug is prescribed to treat the side effects of another drug.
Start Low, Go Slow
Dosing principle to minimize toxicity in older adults.
Nonadherence in Older Adults
Common due to financial, sensory, cognitive, and manual dexterity issues.
Nursing Process Across Lifespan
Assessment: age, allergies, diet, sensory/cognitive deficits, organ function, med list, resources, support.
Planning: human needs statements (nutrition, perception, safety).
Implementation: Nine Rights, teaching, safe handling. Pediatric—disguise taste, avoid calling meds “candy.” Older adults—written large-print instructions, monitor polypharmacy.
Evaluation: monitor therapeutic vs. adverse effects, adjust as needed
Pediatric Taste-Masking in Administration
Disguise medication taste to improve acceptance in children.
Older Adults - Communication and Polypharmacy
Provide large-print instructions and monitor polypharmacy to reduce errors.
Key Exam Points for Lifespan Pharmacology
Differentiate pediatric vs. older adult pharmacokinetics; memorize labeling systems; calculate safe pediatric doses (mg/kg); recognize Beers Criteria and polypharmacy; apply Nine Rights across the lifespan.